Guidelines

Biogen discontinue Alzheimer treatment; The American Academy of Dermatology issue new acne vulgaris management guidelines; Update for ongoing Paxlovid availability; Narcolepsy/ADHD treatment recalled; FDA warn against copycat eye drop products.